By Heidi Bell, Growth Director, Inizio Evoke Europe
One of the standout sessions for me at Reuters Pharma Europe this week was Stephen Wood from Microsoft talking about “Frontier Transformation.”
Not because it was full of new buzzwords, but because it clarified something many of us are already feeling. This isn’t about AI as a tool anymore. It’s about redesigning how work actually gets done.
A few things that stuck with me:
The gap is already opening
Frontier pharma organizations, those really embedding AI, are seeing growth strength of 88% vs. 23% for laggards. That’s not marginal. That’s a structural shift.
85% of pharma workflows can be transformed
We’ve moved past the “nice-to-have use cases” phase. The scale of opportunity is massive, and it makes standing still a bigger risk than moving forward.
The smartest players aren’t chasing 100 use cases
They’re focusing on “centers of gravity,” the moments that actually move the needle. It’s a good reminder that prioritization beats proliferation.
Trust isn’t a blocker. It’s an accelerator
The organizations moving fastest are the ones investing in governance, identity, and observability early. Building trust is what unlocks scale.
And maybe most importantly, AI is shifting from efficiency to transformation
This isn’t just about doing the same things faster. It’s about enabling entirely new ways of working, new roles, and new kinds of impact.
There was also a clear arc to how this evolves. From humans using AI, to humans working with agents, to humans leading systems of autonomous agents across the value chain.
For pharma, the intent is already there. 94% are planning or actively using agentic AI. The question now isn’t if, it’s how, and how fast.
From an Inizio Evoke perspective, it reinforces something we’ve been leaning into. This is about more than technology. It’s about connecting data, creativity, and human insight in ways that actually matter to patients and HCPs.
AI should make health more human, not less.
Interested in hearing more? Connect with us here.